Medical/Pharmaceuticals

Samsung Biologics reports second quarter 2025 financial results

* Recorded Q2'25 consolidated revenue of KRW 1,289.9 billion * Recorded Q2'25 consolidated operating profit of KRW 475.6 billion * Solid momentum sustained through capacity ramp-up and stable project execution INCHEON, South Korea, July 23, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940...

2025-07-23 14:54 2231

BostonGene Receives Frost & Sullivan's 2025 North American Enabling Technology Leadership Award for Redefining Precision Oncology with AI and Multiomics Innovation

BostonGene's comprehensive AI-powered platform integrates multiomics data to accelerate discovery, reduce development risk and advance precision oncology across all stages the R&D continuum SAN ANTONIO, July 22, 2025 /PRNewswire/ -- Frost & Sullivan has named  BostonGene the recipient of the 2025...

2025-07-22 22:00 2152

A novel oral treatment for Alzheimer's: Actinogen's pivotal trial currently recruiting participants in the US

All 20 US trial sites are now open in the XanaMIA phase 2b/3 trial that is studying oral Xanamem® vs. placebo for 36 weeks, followed by an open label extension of active Xanamem for up to 24 months SYDNEY, July 22, 2025 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) is encouraging individu...

2025-07-22 20:00 2090

Telix Reports $204M Revenue, Up 63% YOY

MELBOURNE, Australia and INDIANAPOLIS, July 22, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides an update on its commercial and operational performance for the quarter ended30 June 2025 (Q2 2025). All figures are in USD unless stated otherwise. ...

2025-07-22 16:02 2607

METiS Technologies Showcases AI-Powered Nanodelivery Platform at the 2025 Controlled Release Society Annual Meeting

HANGZHOU, BEIJING, China and CAMBRIDGE, Mass., July 22, 2025 /PRNewswire/ -- METiS Technologies, a global leader in AI-driven nanodelivery innovation, today announced the presentation of its latest research findings at the poster session of the 2025 Controlled Release Society (CRS) Annual Meeting...

2025-07-22 15:52 2543

DualityBio's Next-Generation HER3 ADC DB-1310 Granted FDA Fast Track Designation

SHANGHAI, July 21, 2025 /PRNewswire/ -- DualityBio (HKEX Stock Code: 9606.HK) announced thatthe U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to its next-generation HER3-targeting antibody-drug conjugate (ADC) DB-1310. This designation is for the treatment of ad...

2025-07-22 10:25 2308

Precision Era to Redefine Treatment, Drive $450B Economic Investment and Change Lives Across Asia Pacific

SINGAPORE, July 22, 2025 /PRNewswire/ -- The Precision Era of medicine is arriving inAsia Pacific, driven by the arrival of a critical mass of innovative therapies that will redefine treatment, attract investment and improve lives, a new expert-driven report finds. Released today, 'On the Cusp o...

2025-07-22 10:07 2863

OMRON Healthcare Singapore partners with bolttech and QBE to launch innovative embedded health solution

The comprehensive subscription programme offers OMRON customers in Singapore access to personalised health protection and insights SINGAPORE, July 22, 2025 /PRNewswire/ -- Global insurtech bolttech and OMRON Healthcare Singapore, a global leader in innovative medical equip...

2025-07-22 09:30 3605

2025 Inaugural Global Chest Wall Surgery Conference Concludes Successfully: Uniting Expertise, Driving Innovation

GUANGZHOU, China, July 21, 2025 /PRNewswire/ -- The inaugural Global Chest Wall Surgery Conference concluded successfully inGuangzhou on July 19, uniting leading medical experts worldwide to share cutting-edge surgical innovations and clinical insights inchest wall surgery

2025-07-21 22:33 1947

ICWS Successfully Concludes 2nd Global Program on Cutting-edge Chest Wall Surgery Techniques

GUANGZHOU, China, July 21, 2025 /PRNewswire/ -- The 2nd "Latest Chest Wall Surgery Technique Global Training Program", hosted bythe Institute of Chest Wall Surgery (ICWS) of Guangdong Second Provincial General Hospital, was successfully held fromJuly 16 to 18, 2025. Th...

2025-07-21 22:32 1723

BON Announces $22 Million Distribution Agreement for Weight Loss Products with Beijing Huahai Keyuan Technology Co., Ltd

XI'AN, China, July 21, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural health and personal care industries, today announced it has entered into a non-exclusive sales distribution agreement w...

2025-07-21 21:00 2819

Bloomage Achieves FDA GMP Audit with Zero-Deficiency, Reinforcing Global Trust

PARSIPPANY, N.J., July 21, 2025 /PRNewswire/ -- Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, has announced it successfully passed the U.S. Food and Drug Administration (FDA)'s on-site GMP audit with a "No Action Indicated" (NAI) result. This is the best ...

2025-07-21 21:00 1645

Minaris Advanced Therapies Welcomes Orla Cloak as Chief Executive Officer

PHILADELPHIA, July 21, 2025 /PRNewswire/ -- Minaris Advanced Therapies is pleased to announce the appointment ofDr. Orla Cloak as Chief Executive Officer.  Dr. Cloak is a seasoned executive with over 20 years of commercial leadership experience in the Pharma and Life Science industries. She brin...

2025-07-21 21:00 2017

CPHI & PMEC Shenzhen 2025: Unlocking New Opportunities in Asia and the Greater Bay Area

SHANGHAI, July 21, 2025 /PRNewswire/ -- CPHI & PMEC China 2025 concluded in June with a record-breaking 109,056 attendees, underscoring strong demand within China's thriving pharma industry.  Building on this success, CPHI & PMEC Shenzhen 2025  will tak...

2025-07-21 14:31 2241

CorestemChemon Expands Global CRO Reach with ATG Lifetech, Targeting Next-Gen Preclinical Services

Strategic partnership to deliver transcriptomics-powered, organoid-based preclinical testing for high-impact drug discovery  SEOUL, South Korea, July 20, 2025 /PRNewswire/ -- CorestemChemon, a leading GLP-certified preclinical CRO based inSouth Korea, has entered into a strategic partnership wit...

2025-07-21 10:54 1714

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to use FDA-approved novel wireless system to treat cardiac arrhythmias

AUSTIN, Texas, July 21, 2025 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first in the nation to implant an FDA-approved novel leadless system that provides cardiac resynchronization therapy to patients wit...

2025-07-21 08:47 2012

Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management

BEIJING, July 18, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, a leading global healthcare company, at the 3rd China International Supply Chain Expo in Beijing. Leve...

2025-07-18 20:04 2854

DNAKE Emerges as a Global Innovator in Brain-Computer Interface Technology

XIAMEN, China, July 18, 2025 /PRNewswire/ -- Brain-Computer Interface (BCI) technology is redefining human-machine interaction by establishing direct communication between the brain and external devices. This transformative innovation is driving profound societal impact across industries: revolu...

2025-07-18 16:19 2200

Getinge Interim Report April-June 2025: Continuing positive trend with stable organic sales growth in all business areas and regions

GOTHENBURG, Sweden, July 18, 2025 /PRNewswire/ -- "The positive start to 2025 continued in the second quarter, with stable organic growth in order intake and sales, and our margins strengthened despite strong headwinds from tariffs and negative currency effects," says Mattias Perjos, President & ...

2025-07-18 14:29 1887

The World Federation of Neurology to Host Global Webinar Uniting UN-ECOSOC, WHO and Leading Brain Health Experts for World Brain Day 2025, with the theme Brain Health for All Ages

LONDON, July 18, 2025 /PRNewswire/ -- On July 22, the World Federation of Neurology (WFN) will celebrate its 12th annual World Brain Day, with the theme "Brain Health for All Ages." The official event of World Brain Day is awebinar, open to the public, taking place at 1:00 p.m. BST.

2025-07-18 14:00 2692
1 ... 64656667686970 ... 646

Week's Top Stories